Rani Therapeutics Holdings (RANI) Net Margin (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly Net Margin of 606.21% for Q1 2026, up 679961.0% year-over-year from N/an in Q1 2025, and down 2.66% quarter-over-quarter from 590.49% in Q4 2025.
Rani Therapeutics Holdings (RANI) Net Margin (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Net Margin history runs 5 years deep, the most recent figure standing at 606.21% for Q1 2026.
- In Q1 2026, Net Margin rose 679961.0% year-over-year to 606.21%; the TTM figure through Mar 2026 stood at 1332.79% (up 336846.0% YoY), while the FY2025 annual figure was 7136.56%, down 163228.0% from the prior year.
- Net Margin for Q1 2026 stood at 606.21%, down from 590.49% in the prior quarter.
- The five-year high for Net Margin was 590.49% in Q4 2025, with the low at 7405.81% in Q1 2025.
- The 3-year median for Net Margin is 894.98% (2026), against an average of 2446.57%.
- The sharpest annual moves came in 2025 and 2026: Net Margin surged 59327 bps in 2025, then jumped 679961 bps in 2026.
- Rani Therapeutics Holdings' Net Margin stood at 1183.75% in 2024, then surged by 50 bps to 590.49% in 2025, then slipped by 3 bps to 606.21% in 2026.
- Business Quant data shows RANI's Net Margin at 606.21% in Q1 2026, 590.49% in Q4 2025, and 7405.81% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 12.74% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -3.12% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -16.51% |
| 10 | Rani Therapeutics Holdings | 160.33 Mn | 160.33 Mn | - | -493.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -729.27% |
| Mar 31, 2026 | -606.21% |
| Dec 31, 2025 | -590.49% |
| Mar 31, 2025 | -7,405.81% |
| Dec 31, 2024 | -1,183.75% |
| Jun 30, 2021 | -279.70% |
| Mar 31, 2021 | -740.48% |
| Dec 31, 2020 | -2,740.95% |
| Sep 30, 2020 | -2,669.44% |
| Jun 30, 2020 | -4,523.33% |